Intel Leader VR Medical EchoPixel Receives $8.5 Million Series A Financing
Technology company EchoPixel announced the completion of a $ 8.5 million Series A round of financing. This investment was led by the new capital, Intel Capital.
EchoPixel's core technology is VR technology for clinicians. The True 3D program uses existing DICOM (Digital Imaging and Communications in Medicine) data to deliver life-size, interactive medical images so that doctors can observe, interact, and even perform "dissections" at specific sites. Can be used for diagnostic and surgical purposes.
The company’s announcement stated that the True 3D platform allows doctors to have a series of “holographic experiences†in clinical applications—whether in preoperative planning and surgical reference, patient transplant equipment, improving the efficiency of surgical team communication, or improving patients For the understanding of surgery, so as to achieve better recovery treatment aspects.
Wendell Brooks, chairman of Intel Capital, said that the company is excited about investing in EchoPixel and seeing their technology changing the patient care process through the use of AR technology.
This technology has been used in many of the top medical centers in the United States, including Yale New Haven Hospital, Hershey Medical Center, Stanford, and Cleveland Clinic.
Ron Shilling, the company’s executive chairman, said: “The number of well-known medical centers that use True 3D and the number of institutions that support EchoPixel’s marketing are increasing, which makes the company’s rapid development.†EchoPixel said it will use this Money to expand its business, R & D and regulatory scale.
In addition to Intel, the companies participating in this round were the two new employers, LAM Research and Binomial, as well as the former Aurus Capital, Runa Capital and Harris & Harris Group companies.
SHENZHEN CHONDEKUAI TECHNOLOGY CO.LTD , https://www.szsiheyi.com